MedTrace Logo

A Non-drug Study Profiling Cutaneous Lupus

NCT01923415 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2014-09-12

No results posted yet for this study

Summary

The purpose of this study is to characterize the clinical and molecular profiles of patients with cutaneous lupus.

Conditions

  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Systemic
  • Lupus Erythematosus, Discoid

Interventions

PROCEDURE

No intervention, skin biopsy

All participants will have 2 adjacent 4 mm punch biopsies collected from uninvolved and involved skin (a total of 4 biopsies).

PROCEDURE

No intervention, blood collection

Blood for serum analyses will be taken from all participants, blood for DNA analysis only from subjects who consent to this separately.

PROCEDURE

No intervention, urine collection

Urine will be collected from all participants.

Sponsors & Collaborators

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC Clinical Study · Janssen Research & Development, LLC

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • United States
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01923415 on ClinicalTrials.gov